Friday, March 29, 2024
ADVT 
International

Britain to test mixing and matching of COVID-19 vaccines

Darpan News Desk The Canadian Press, 04 Feb, 2021 01:12 AM
  • Britain to test mixing and matching of COVID-19 vaccines

British scientists are starting a study Thursday to find out if it's OK to mix and match COVID-19 vaccines.

The vaccines being rolled out now require two doses, and people are supposed to get two shots of the same kind, weeks apart.

Guidelines in Britain and the U.S. say the vaccines aren't interchangeable, but can be mixed if the same kind isn’t available for the second dose or if it’s not known what was given for the first shot.

Participants in the government-funded study will get one shot of the AstraZeneca vaccine followed by a dose from Pfizer, or vice versa.

“This study will give us greater insight into how we can use vaccines to stay on top of this nasty disease,” said Jonathan Van Tam, the U.K.'s deputy chief medical officer.

He said that given the challenges of immunizing millions of people amid a global vaccine shortage, there would be advantages to having data that could support more “flexible” immunization campaigns.

COVID-19 vaccines all train the body to recognize the coronavirus, mostly the spike protein that coats it. The ones from AstraZeneca and Pfizer use different technologies. AstraZeneca's uses a common cold virus to carry the spike gene into the body. Pfizer's is made by putting a piece of genetic code called mRNA — the instructions for that spike protein — inside a little ball of fat.

The British research is scheduled to run 13 months and will also test different intervals between doses, four weeks and 12 weeks apart.

A study published this week on the Russian-made Sputnik V vaccine showed it was about 91% effective in preventing COVID-19. Some immunologists credit the fact that the vaccine uses two slightly different shots, made with similar technology to AstraZeneca's.

But the AstraZeneca and Pfizer vaccines are "so different that it’s really hard to know if that would work,” said Alexander Edwards, an associate professor in biomedical technology at Britain's University of Reading.

Matthew Snape, the new study's leader at Oxford University, which helped develop the AstraZeneca vaccine, called for British volunteers over age 50 to sign up; scientists are hoping to enrol more than 800 people.

If the vaccines can be used interchangeably, "this will greatly increase the flexibility of vaccine delivery," he said in a statement. "(It) could provide clues as to how to increase the breadth of protection against new virus strains.”

In recent weeks, Britain, the European Union and numerous other countries have been hit with vaccine supply issues: AstraZeneca said it would dramatically reduce the expected number of doses it could deliver due to manufacturing delays and Pfizer also slowed deliveries while it upgraded its Belgian factory.

MORE International ARTICLES

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Pfizer seeking emergency use of its COVID-19 vaccine in US

Some of Trump's trade legacy to linger under Biden

Some of Trump's trade legacy to linger under Biden
Future administrations, be they Democrat or Republican, are unlikely to forget the lessons of 2016 any time soon, a panel of trade experts agreed Thursday.

Some of Trump's trade legacy to linger under Biden

Leaders honour veterans ahead of Remembrance Day

Leaders honour veterans ahead of Remembrance Day
Prime Minister Justin Trudeau, along with other federal party leaders, rose in the House of Commons Thursday to pay their own tributes ahead of the Nov. 11 commemorations.

Leaders honour veterans ahead of Remembrance Day